Bionoid Pharma Stock Today

BINP Stock  USD 0.09  0.01  13.27%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Quite High

 
High
 
Low
Bionoid Pharma is selling at 0.085 as of the 18th of March 2025; that is 13.27 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.085. Bionoid Pharma has more than 69 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people. The company has 42.28 M outstanding shares. More on Bionoid Pharma

Moving against Bionoid Pink Sheet

  0.91TAK Takeda PharmaceuticalPairCorr
  0.86TKPHF Takeda PharmaceuticalPairCorr
  0.79CMSQF Computershare LimitedPairCorr
  0.77FARM Farmer BrosPairCorr
  0.73HLN Haleon plcPairCorr
  0.71SGAPY Singapore TelecommunicatioPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bionoid Pink Sheet Highlights

Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Bionoid Pharma [BINP] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bionoid Pharma's market, we take the total number of its shares issued and multiply it by Bionoid Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bionoid Pharma conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 42.28 M outstanding shares. Bionoid Pharma currently holds about 127 in cash with (357.62 K) of positive cash flow from operations.
Check Bionoid Pharma Probability Of Bankruptcy

Bionoid Pharma Risk Profiles

Bionoid Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bionoid Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Additional Tools for Bionoid Pink Sheet Analysis

When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.